Neostem Set to Become First Fully Commercial Stem Cell Medicine Play
BioMedReports.Com, the news portal which covers Wall Street’s biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting that Neostem’s (NYSE Amex: NBS …
[Read the full article here]Related News:
Neostem Set to Become First Fully Commercial Stem Cell …
News and FDA Updates for Stem Cell Therapy , SuperGen …
News and FDA Updates for Stem Cell Assurance (OTC:SCLZ …